Author

D. Afendoulis

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Clinical determinants of systemic inflammation in a real-world heart failure cohort

- Systemic inflammation plays a central role in cardiovascular disease and has been implicated in the pathophysiology of heart failure (HF). High-sensitivity C-reactive protein (hsCRP) represents an accessible marker of low-grade inflammatory activity; however, the clinical determinants of elevated hsCRP within h...

F. Psyllou, S. Bouloukou, D. Afendoulis et al. · European Heart Journal · 0 citations

Review Open access Oct 2026

Cancer Activity and Clinical Outcomes After Percutaneous Coronary Intervention: A Systematic Review of Bleeding, Ischemic Events, and Evidence Gaps

Cancer activity may modify bleeding and ischemic risk after percutaneous coronary intervention (PCI), but available reports differ in cancer definitions, antiplatelet exposure and follow-up. We reassessed a PROSPERO-registered systematic review (CRD420261350515), originally comprising five observational studies, and un...

Styliani Nikolaidou, L. Koliastasis, M. Moutafi et al. · Life · 0 citations

Open access Oct 2026

Safety and effectiveness of drug-coated balloon angioplasty in de novo coronary lesions: 6-month outcomes from a multicenter registry

Drug-coated balloon (DCB) angioplasty has emerged as a promising alternative to drug eluting stent (DES) implantation, particularly in small-vessel coronary disease (defined as target vessels with a reference diameter ≤2.75 mm). Nevertheless, multicenter real-world data focusing exclusively on de novo lesions remain...

N. Tsiamis, A. Papanikolaou, F. Toulgaridis et al. · European Heart Journal · 0 citations